What is the treatment of patient blood?

Patient blood control is a multilateral program to reduce or eliminate the need for patients to undergo blood transfusions. Emphasis is placed on all patients undergoing surgery, knowing that those who already suffer from anemia are more at risk of transfusions. The blood management team assesses and formulates a plan for the specific needs of each individual before and after the operation. The plan includes medical techniques to prevent blood, drug loss and laboratory analysis. This procedure approach also covers all aspects concerning the patient's evaluation, to the actual decision -making that goes to the recommendation of blood transfusion.

The program deals with a number of problems that include the maintenance of blood resources, minimizing unnecessary blood use, shortening the time spent in the hospital, and also taking into account the costs of the patient and the medical facility. Pharmacists are a key part of blood management programs often provides advice on relevant medicines that can be used for limitedAllogenic blood transfusion needs. This procedure, which is essentially blood donated from several anonymous donors, can be costly, which is just one of the fear of the medical community.

Patient blood control is an important aspect during the perioperative cycle. This applies to the general time that every patient spends in a hospital environment and involves accepting, surgery and recovery time. To maximize and improve their efforts, teams for patient blood management try to ensure that anemic patients are correctly diagnosed and supplied with the appropriate and adequate amount of spare blood. The team continues to monitor the patient after surgery to ensure that their blood work remains normal. Patients are usually examined for anemia at least one month before surgery, so blood management can take further measures.

Blood donated for transfusion purposes sometimes comes with the risk of infectionor. This is an essential part of blood treatment by a patient who ensures that these diseases do not enter the transfusion process and finally the patient. Viruses such as hepatitis, human immunodeficiency virus (HIV) and the West Nile virus are just a few potentially deadly candidates who could get into the allogenic blood banks. Studies have shown that although allogenic blood transfusions will undoubtedly save many lives, they are also associated with increased death and medical complications. For this reason, the Blood Management Team is commissioned to be particularly alert during the donation screening process.